Chief Executive Officer: Heather Helle
Heather Helle is the Chief Executive Officer of DermOne. She has more than 15 years of diverse experience serving in roles of increasing responsibility across the healthcare services and packaged goods industries. She has held leadership roles in operations, marketing and innovation. Heather has worked domestically and internationally and has a track record of delivering outstanding results for both emerging and mature businesses.
Prior to her position at DermOne, Heather was the divisional vice president of Walgreens Healthcare Clinics. In this capacity, she was responsible for leading the company’s retail clinic business within Walgreens pharmacies. She successfully led its transformation and expansion from 50 clinics focused on acute care to more than 400 clinics delivering preventive, diagnostic and treatment services. Heather held management responsibility for more than 1,400 team members and collaborated cross-functionally across the multiple Walgreens businesses and functions. She represented the company’s efforts both internally and externally and has been featured on NPR’s Marketplace, in The Washington Post and The Wall Street Journal.
Previous to Walgreens, Heather served as director of the $745 million Adult Upper Respiratory brand for McNeil Consumer Healthcare, a Johnson & Johnson company. She is credited with both the successful integration of the Pfizer Upper Respiratory portfolio and the organizational response to the pseudoephedrine crisis, which led to record sales and market share gains. She was presented with the Johnson & Johnson Standards of Leadership award in recognition of her accomplishments. Before Johnson & Johnson, she served in various roles in marketing and promotions at General Mills Inc.
Heather graduated from the University of Minnesota with a bachelor’s degree in business, and she graduated from the Kellogg School of Management at Northwestern University with a master’s degree in business administration.
Chief Operating Officer: Dave Nelson
Dave Nelson is the Chief Operating Officer of DermOne. He has over 25 years’ experience in a series of diverse roles within healthcare products and services markets. He has held leadership positons in Operations, Strategy, Contracting, and Sales with local, regional and national responsibility.
Prior to DermOne, Dave served as the Chief Strategy Officer for ATI Physical Therapy, a national Outpatient Physical Therapy company based in Bolingbrook, IL. He led sourcing of 20 completed acquisitions in 28 months, successfully expanding ATI’s footprint from 225 clinics to over 600 and from 13 states to 24. Dave’s additional responsibilities included Facility and DeNovo, Organizational Strategy, Contracts and Pricing, Research and Data Analytics, and Product Management. Dave was a foundational leader and active contributor to the completion of ATI’s fourth and largest recapitalization with its new Private Equity Partner, Advent International.
Previous to ATI, Dave served in multiple roles with escalating responsibility with Coram Specialty Infusion Services. Over a period of 13 years he served as VP Operations with full P&L responsibility for $300M in annual revenues.
Dave graduated from Allegheny College with two bachelor degrees in economics and psychology with a thesis focusing on International Healthcare Systems, and he graduated from Baldwin Wallace University with a master’s degree in business administration focused on healthcare administration in one of the country’s first healthcare specific MBA programs including Northeast Ohio University College of Medicine.
Chief Medical Officer: Dr. Andrew Krakowski
Dr. Krakowski serves as the Chief Medical Officer of DermOne. He is a board-certified dermatologist and subspecialty board-certified pediatric dermatologist with a clinical research focus on the application of lasers and photomedicine in children. Dr. Krakowski earned his medical degree from the University of Pennsylvania and completed a residency in pediatrics at the Johns Hopkins Medical Institute. He trained in dermatology at the University of California, San Diego, and served as chief resident in his final year. He completed additional specialty training as a two-year research fellow and as a one-year clinical fellow in pediatric dermatology at Rady’s Children’s Hospital-San Diego, where he served as a practicing physician, a full-time assistant professor and the founding director of medical innovation.
Dr. Krakowski is a nationally renowned laser expert with over 50 peer-reviewed publications including expert recommendations on the treatment of preadolescent acne and two groundbreaking articles on scar revision and wound healing in epidermolysis bullosa. As an appointed member of the National Pediatric Acne Guidelines Initiative, Dr. Krakowski helped produce the first detailed, evidence-based clinical guidelines for the diagnosis and treatment of pediatric acne, which were endorsed by the American Academy of Pediatrics and published in Pediatrics in May 2013. He is also co-editor of the first definitive textbook on scar formation, revision, mitigation and prevention, scheduled to be published in 2016.
Dr. Krakowski regularly serves as an invited lecturer and course director at the annual meetings of the American Academy of Dermatology, the American Academy of Pediatrics and the American Society for Laser Medicine and Surgery. He is the pediatric dermatology editor for Practical Dermatology, “Spot the Rash,” in Infectious Diseases in Children and for the Journal of Clinical and Aesthetic Dermatology. He also founded the Society for Pediatric Dermatology’s “Patient Perspectives” initiative, a monthly feature in the peer-reviewed journal Pediatric Dermatology. The American Academy of Dermatology has awarded Dr. Krakowski a Gold Triangle for public health service to the dermatologic community and, in 2013, he received the first U.S. Dermatologist from the Heart award from LaRoche-Posay for his work with scar patients.
Chief Financial and Administrative Officer: Jeff Petrick
Jeff Petrick serves as the Chief Financial and Administrative Officer of DermOne. He has over 25 years of finance and accounting leadership experience across the healthcare, manufacturing and travel industries. He held key roles in the completion of two sales of private companies to top-50 public companies and two successful IPOs. Jeff has worked for both private and public companies in the domestic and international markets, and has a track record of delivering outstanding results for emerging and mature businesses.
Before DermOne, Jeff served as chief financial officer for Walgreens Healthcare Clinics and Walgreens’ worksite health center businesses. He was instrumental in compiling the Walgreens Healthcare Clinics business plan; establishing the baseline business foundation and funding for the startup; leading the financial due diligence in the multimillion dollar equity offering in 2006; and directing the financial due diligence in the successful sale of the business to Walgreens in 2007.
Before Walgreens, Jeff served as vice president, corporate controller and chief accounting officer of EnerSys, the global leader in stored energy solutions for industrial applications with over $2 billion in sales. He was instrumental in the completion of EnerSys’ IPO and instituting policies, procedures and processes throughout the worldwide entity to meet SEC reporting and disclosure requirements. Before EnerSys, he served as vice president global finance and corporate controller of Rosenbluth International Inc., which was one of the world’s top-five companies globally specializing in corporate managed travel, with $3 billion in sales. He was a key leader in the sale of the company to American Express Co.
Jeff graduated from Villanova University with a bachelor’s degree in accounting, cum laude. He is a certified public accountant.
Chief People Officer: Pam Teufel
Pam Teufel serves as Chief People Officer at DermOne. Before joining DermOne, she was the executive vice president and chief human resources officer at Thomas Jefferson University and Jefferson Health System. Jefferson is an academic medical center in Philadelphia with over 18,000 employees, and includes five hospitals, several physician practices with over 1,000 physicians, and the second-oldest Medical College in the country. In her capacity as CHRO, Pam was responsible for the entire HR delivery model and talent management strategies. In just a year, she designed and implemented a new shared-services and business partner model. She also implemented a robust wellness program for employees and faculty.
Before joining Jefferson, Pam served as vice president of human resources at Temple University Health System in Philadelphia, with 6,600 employees. At Temple, she created the first workforce strategic plan for the health system with measurable annual performance objectives, created a new performance appraisal system with a redesign of all job descriptions, led the organization through a 30-day strike, and built a total rewards program.
Before Temple, Pam spent five years at the prestigious Scripps Health in San Diego, CA, as senior administrative director of human resources operations and started as administrative director of human resources services. The system spanned five campuses with 15,000 employees. Pam was responsible for employee engagement, labor relations and HR standardization. In California, she also worked for Laboratory Corporation of America for six years as divisional director of human resources and manager of human resources. She began her HR career at Wegmans Food Market Inc. in Ithaca, NY.
Pam has a bachelor’s degree in communications from Ithaca College and a master’s degree in business administration with a concentration in human resources from Strayer University.
Chief Business Development Officer: Nate Horvath
Nate Horvath is the Chief Business Development Officer of DermOne. He has over 20 years of diverse experience in investing, mergers and acquisitions, and finance and accounting across a broad range of industries including healthcare services, manufacturing, retail and consumer products.
As a Managing Director of DermOne’s primary investor, Westwind Investors, Nate also serves on the Board of DermOne. At Westwind, Nate is a senior investment professional and in addition to overseeing the firm’s operations, Nate is responsible for sourcing, investing and managing the firm’s direct private equity and real estate investments. Westwind takes an active and involved approach to investing and Nate often serves as the operating partner for Westwind’s companies.
Prior to joining Westwind in 2008, Nate was a Vice President with American Capital where he was responsible for making both debt and equity investments in middle-market companies. Previously, Nate was a Senior Manager at Ernst & Young where he led due diligence for his clients on dozens of companies in a broad range of industries. Prior to E&Y, Nate worked in corporate finance at a technology firm, where he led the financial analysis and due diligence processes for numerous acquisitions. Nate began his career at Arthur Andersen and is a licensed CPA.
Nate received his MBA from the Stanford Graduate School of Business and graduated summa cum laude from the University of Illinois at Chicago with a B.S. in Accounting. Nate is also a former Marine and was a security forces team leader during the Persian Gulf War.
Director of Compliance & Privacy: Jeffrey Miller
Jeffrey Miller serves as DermOne’s Director of Compliance and Privacy. Jeffrey is an attorney and compliance professional with extensive experience in transactional matters, representation and negotiations in commercial matters and before government authorities, risk assessment and management, corporate compliance and privacy.
Prior to his role at DermOne, Jeffrey served as vice president, global compliance officer with Biomet 3i, where he managed Biomet 3i’s compliance with its deferred prosecution agreement, led and developed Biomet 3i’s global compliance function, and prepared, positioned and managed Biomet 3i’s compliance organization through a $13.5 billion acquisition by Zimmer. Prior to this position, he was vice president with DePuy Synthes Companies, part of Johnson & Johnson, where he led DePuy Synthes’ compliance with its corporate integrity agreement. He joined Johnson & Johnson through its acquisition of Synthes, where he was vice president, chief compliance officer and counsel.
Before Synthes, Jeffrey worked as associate corporate counsel for Mercy Health System of Southeastern Pennsylvania. Before that position, he counseled and represented clients in the private practice of law, including individual physician practices and nursing facilities.
Jeffrey is a recipient of the Yale School of Management, Millstein Center for Corporate Governance and Performance’s Rising Star of Corporate Governance Award for his contributions to the fields of corporate compliance, risk management and corporate governance. He is a member of Wolters Kluwer Law and Business’ Health Law Advisory Board. As a faculty member of the Pennsylvania Bar Institute, Jeffrey has regularly taught on health law related topics since 2002. Jeffrey was an establishing member of the European Network of Integrity / Compliance Officers, and is also an active member of the American Health Lawyers Association, the Health Care Compliance Association and other professional organizations.
He is a graduate of the Widener University, Commonwealth Law School, and the Pennsylvania State University, Smeal College of Business Administration.